Clinical Trials Directory

Trials / Completed

CompletedNCT06178367

Effectiveness and Safety of Topical Hyaluronic Acid of Different Molecular Weights in Xerotic Skin Treatment

Effectiveness and Safety Comparison Between Moisturizers Containing Low Molecular Weight Hyaluronic Acid, High Molecular Weight Hyaluronic Acid, and Vehicle on Skin Hydration in the Elderly With Xerotic Skin

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Indonesia University · Academic / Other
Sex
All
Age
60 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to compare 0,1% topical low molecular weight (7 kDa) hyaluronic acid with 0,1% high molecular weight (1.800 kDa) hyaluronic acid as therapy of xerotic skin in elderly

Detailed description

This clinical trial is conducted to compare the effectiveness and safety between moisturizers containing 0,1% low molecular weight hyaluronic acid, 0,1% high molecular weight hyaluronic acid, and its vehicle on skin hydration of elderly with xerotic skin. It is designed to answer following questions: 1. Is the skin capacitance in the elderly after using moisturizers containing low molecular weight hyaluronic acid higher than high molecular weight hyaluronate acid and vehicle? 2. Is the transepidermal water loss in the elderly after using moisturizers containing high molecular weight hyaluronic acid lower than low molecular weight hyaluronate acid and vehicle? 3. Is the dry skin score (SRRC) in the elderly after using moisturizers containing low molecular weight hyaluronic acid lower than high molecular weight hyaluronate acid and vehicle? 4. Is there any difference in occurence of side effect in elderly between the use of moisturizers containing low molecular weight hyaluronic acid, high molecular weight hyaluronic acid, and vehicle?

Conditions

Interventions

TypeNameDescription
DRUGLow molecular weight hyaluronic acidTopical 0,1% low molecular weight (7 kDa) hyaluronic acid in vehicle
DRUGHigh molecular weight hyaluronic acidTopical 0,1% high molecular weight (1.800 kDa) hyaluronic acid in vehicle
DRUGVehicleVehicle ingredients including aqua, paraffinum liquidum, glycerin, petrolatum, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, arachidyl alcohol, squalane, behenyl alcohol, phenoxyethanol, arachidyl glucoside, allantoin, chlorphenesin, and disodium EDTA

Timeline

Start date
2023-08-26
Primary completion
2023-09-30
Completion
2023-09-30
First posted
2023-12-21
Last updated
2024-04-30

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT06178367. Inclusion in this directory is not an endorsement.